Bio-Gene Technology (ASX:BGT) Buyback Yield %: -14.32 (As of Jul. 07, 2026)


What is Bio-Gene Technology Buyback Yield %?

Bio-Gene Technology ASX:BGT Buyback Yield % is -14.32 as of Jul. 07, 2026. The stock has 2 warning signs investors should review. Among 740 Biotechnology companies, Bio-Gene Technology ranks worse than 60% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Bio-Gene Technology's current buyback yield was -14.32%.

Bio-Gene Technology Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Buyback Yield % Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial -0.96 -22.49 0.00 -20.06 -33.31

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.38 -20.06 0.00 -33.31 -13.40

ASX:BGT vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Bio-Gene Technology's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Gene Technology Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Gene Technology's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Bio-Gene Technology's Buyback Yield % falls into.


Bio-Gene Technology Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Bio-Gene Technology's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (-0.076 + 1.496) / 4.262704
=-33.31%

Bio-Gene Technology's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (-0.025 + 0.965) / 7.016403
=-13.40%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -14.32 mean?
Bio-Gene Technology (ASX:BGT) has a Buyback Yield % of -14.32 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Bio-Gene Technology and its competitors. According to the industry distribution chart, Bio-Gene Technology ranks #444 out of 740 companies in the Biotechnology industry, placing it in the top 60%.
Is Bio-Gene Technology's Buyback Yield % too high?
Bio-Gene Technology's current Buyback Yield % is -14.32. Based on the distribution chart, Bio-Gene Technology ranks #444 out of 740 companies in the Biotechnology industry, which is below the industry midpoint.
How does Bio-Gene Technology's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bio-Gene Technology ranks #444 out of 740 companies for Buyback Yield %. This places Bio-Gene Technology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Buyback Yield % is -14.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Buyback Yield % of -14.32. The current Buyback Yield % is -14.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Buyback Yield % is -14.32 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.